VivoSeq
Other

Labor Induction

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Labor Induction is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

16/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed12 · 48%
Unknown status6 · 24%
Terminated2 · 8%
Not yet recruiting2 · 8%
Withdrawn2 · 8%
Recruiting1 · 4%

Trial Activity

25 trials

Mifepristone for Labor Induction
Completed·SStanford University·Phase 3·NCT05097326·30 enrolled
Effect of Dexamethasone on Labor Induction
Completed··Phase 3·NCT05070468·84 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)